Sentinel community Clostridium difficile infection (CDI) surveillance in Scotland, April 2013 to March 2014

被引:15
|
作者
Banks, A. [1 ]
Brown, Derek J. [2 ]
Mather, Henry [2 ]
Coia, John E. [2 ]
Wiuff, Camilla [1 ]
机构
[1] NHS Natl Serv Scotland, Hlth Protect Scotland, Meridian Court, 5 Cadogan St, Glasgow G2 6QE, Lanark, Scotland
[2] Glasgow Royal Infirm, SSSCDRL, Level 5,New Lister Bldg,10-16 Alexandra Parade, Glasgow G31 2ER, Lanark, Scotland
关键词
Clostridium difficile; CDI; Surveillance; Community; Scotland; MOLECULAR EPIDEMIOLOGY; DISEASE; CARRIAGE; STRAINS; COUNTY; RISK;
D O I
10.1016/j.anaerobe.2015.12.008
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Surveillance of Clostridium difficile infection (CDI) in Scotland does not currently distinguish between CDI cases from hospitals and the community. Therefore, the incidence of CDI in the community is unknown, and the burden of disease and the relationship with the hospital/healthcare setting is not well understood. A one-year sentinel community surveillance programme was initiated in collaboration with five Scottish health boards in 2013 (representing 36% of all CDI cases reported in Scotland). Inclusion criteria were all cases aged >= 15 years with a CDI diagnosis in the community or within 48 h following admission to hospital. CDI cases were categorised according to definitions used by the European Centre for Disease Prevention and Control. 256 CDI cases met the inclusion criteria, of which 158 (62%) were community-associated cases (CA-CDI). This represented 26% of all cases reported during the surveillance period by the participating health boards (n = 614). The overall CA-CDI incidence rate was 9.9 per 100 000 population per year. CA-CDI cases were more likely to be female and younger, compared to hospital acquired cases (HA-CDI). The total proportion of cases that had onset in the community was 27%. Ribotypes 015, 002, 078 and 005 were the most common types isolated from both CA-CDI and HA-CDI cases. There were no statistically significant differences between the proportion of types that were either CA-CDI or HA-CDI. Of the CA-CDI cases, 37% had not received antibiotics in the 12 weeks preceding CDI diagnosis, 4% were resident in care homes, and the case-fatality rate for CA-CDI cases was 5.6% (with a 30-day mortality rate for CA-CDI of 0.44 per 100 000 population per year). This study has shown that a substantial proportion of CDI cases reported in Scotland are community associated and that there are close links between the community and healthcare settings. It is therefore essential to monitor the trends in CDI in the community at a national level. The study also provides evidence for the need to examine the feasibility for development of interventions to reduce the burden in the community in addition to hospitals. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:49 / 53
页数:5
相关论文
共 50 条
  • [21] Is Clostridium difficile infection (Cdi) more difficult to eradicate in patients with diverticulosis?
    Thanjan, Andy
    Southern, William
    Anand, Neeraj
    Yoon, Sonia
    Brandt, Lawrence
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S195 - S195
  • [22] CLOSTRIDIUM DIFFICILE INFECTION IN 2010 Advances in pathogenesis, diagnosis and management of CDI
    Gerding, Dale N.
    Johnson, Stuart
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2011, 8 (02) : 67 - 68
  • [23] INTRACOLONIC VANCOMYCIN (ICV) USE IN SEVERE CLOSTRIDIUM DIFFICILE INFECTION (CDI)
    Forsyth, Lisa
    Natavio, Allycia
    Villalba, Mario
    CRITICAL CARE MEDICINE, 2009, 37 (12) : A432 - A432
  • [24] Impact of an automatic hospital probiotic protocol on Clostridioides (Clostridium) difficile infection (CDI) rates and CDI antibiotic usage in a community hospital setting
    Slain, Douglas
    Georgulis, Amy
    Dermitt, Ron
    Morris, Laura
    Colodny, Stephen M.
    JOURNAL OF INFECTION PREVENTION, 2020, 21 (02) : 72 - 75
  • [25] Diagnostic Value of Repeated Enzyme Immunoassays in Clostridium Difficile Infection (CDI)
    Nemat, Hashim
    Khan, Rabia
    Ashraf, Muhammad
    Matta, Mandeep
    Ahmed, Shahin
    Edwards, Barbara
    Hussain, Roshan
    Lesser, Martin
    Pekmezaris, Renee
    Dlugacz, Yosef
    Wolf-Klein, Gisele
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S179 - S179
  • [26] Frequency and Impact of Clostridium Difficile Infection (CDI) in Hospitalized Patients with Cirrhosis
    Reddy, K. Rajender
    Tandon, Puneeta
    O'Leary, Jacqueline G.
    Wong, Florence
    Garcia-Tsao, Guadalupe
    Kamath, Patrick S.
    Lai, Jennifer Cindy
    Biggins, Scott W.
    Thuluvath, Paul J.
    Fallon, Michael B.
    Vargas, Hugo E.
    Subramanian, Ram M.
    Thacker, Leroy R.
    Bajaj, Jasmohan S.
    HEPATOLOGY, 2018, 68 : 1336A - 1337A
  • [27] Immunosuppressive Treatment as a Risk Factor for the Occurrence of Clostridium Difficile Infection (CDI)
    Luebbert, C.
    Johann, C.
    Kekule, A. S.
    Worlitzsch, D.
    Weis, S.
    Moessner, J.
    Behl, S.
    Seufferlein, T.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2013, 51 (11): : 1251 - 1258
  • [28] Clostridium difficile Infection (CDI) in the Course of Time An Issue Only for the Internist?
    Weis, S.
    John, E.
    Lippmann, N.
    Moessner, J.
    Luebbert, C.
    ZENTRALBLATT FUR CHIRURGIE, 2014, 139 (04): : 460 - 468
  • [29] Standardised surveillance of Clostridium difficile infection in European acute care hospitals: a pilot study, 2013
    van Dorp, S. M.
    Kinross, P.
    Gastmeier, P.
    Behnke, M.
    Kola, A.
    Delmee, M.
    Pavelkovich, A.
    Mentula, S.
    Barbut, F.
    Hajdu, A.
    Ingebretsen, A.
    Pituch, H.
    Macovei, I. S.
    Jovanovic, M.
    Wiuff, C.
    Schmid, D.
    Olsen, K. E.
    Wilcox, M. H.
    Suetens, C.
    Kuijper, E. J.
    EUROSURVEILLANCE, 2016, 21 (29): : 24 - 36
  • [30] Relapse Versus Reinfection: Surveillance of Clostridium difficile Infection
    Kamboj, Mini
    Khosa, Perminder
    Kaltsas, Anna
    Babady, N. Esther
    Son, Crystal
    Sepkowitz, Kent A.
    CLINICAL INFECTIOUS DISEASES, 2011, 53 (10) : 1003 - 1006